A Case of Interstitial Pneumonitis and Pancytopenia Following the Combination Therapy of Pegylated Interferon and Ribavirin / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 69-73, 2011.
Artículo
en Coreano
| WPRIM
| ID: wpr-136335
ABSTRACT
The combination therapy of pegylated interferon and ribavirin is the mainstay of treatment for chronic hepatitis C patients. Anti-viral therapy is commonly associated with side effects such as headache, fever, myalgia, and arthralgia. However, anti-viral therapy can continue because these side effects are mostly mild and can be improved with supportive management. Anti-viral therapy should be stopped promptly if serious side effects, such as interstitial pneumonitis or hemolytic anemia occur, although those serious side effects are rare. There were a few case reports of interferon-related interstitial pneumonitis worldwide. In Korea, one atypical case report of interstitial pneumonitis has been reported, which followed the combination therapy of interferon-alpha and ribavirin in a patient with chronic hepatitis C. We present a case of interstitial pneumonitis and pancytopenia following the combination therapy of pegylated interferon and ribavirin in a patient with chronic hepatitis C.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pancitopenia
/
Polietilenglicoles
/
Ribavirina
/
Proteínas Recombinantes
/
Interferones
/
Interferón-alfa
/
Enfermedades Pulmonares Intersticiales
/
Artralgia
/
Hepatitis C Crónica
/
Fiebre
Límite:
Humanos
País/Región como asunto:
Asia
Idioma:
Coreano
Revista:
Tuberculosis and Respiratory Diseases
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS